Janney Montgomery Scott’s Oragenics OGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-6
Closed -$104K 1014
2016
Q1
$104K Sell
6
-1
-14% -$18.3K ﹤0.01% 1219
2015
Q4
$176K Hold
7
﹤0.01% 1255
2015
Q3
$213K Buy
7
+2
+40% +$81.5K 0.01% 1219
2015
Q2
$126K Sell
5
-1
-17% -$18.2K ﹤0.01% 1926
2015
Q1
$106K Hold
6
﹤0.01% 2295
2014
Q4
$92.5K Hold
6
﹤0.01% 2236
2014
Q3
$145K Sell
6
-1
-14% -$29.8K ﹤0.01% 2092
2014
Q2
$238K Buy
7
+2
+40% +$79K 0.01% 1811
2014
Q1
$238K Buy
5
+2
+67% +$121K 0.01% 1634
2013
Q4
$128K Buy
3
+2
+200% +$104K ﹤0.01% 1872
2013
Q3
$44.7K Buy
+1
New +$55.9K ﹤0.01% 1858

Other funds holding OGEN

Janney Montgomery Scott's OGEN Position: Q2 2016 in Review

Janney Montgomery Scott sold out of Oragenics (OGEN) in Q2 2016, closing a stake of 6 shares — an estimated $104K sold.

Janney Montgomery Scott first reported a position in OGEN in Q3 2013 and held it in 11 quarters. The position peaked at $238K in Q2 2014. 12 funds tracked by Wall St. Rank hold OGEN as of Q2 2016.

  • Janney Montgomery Scott reported no remaining Oragenics position as of Q2 2016 after selling out during the quarter.
  • Janney Montgomery Scott sold 6 Oragenics shares in Q2 2016, an estimated $104K.
  • Janney Montgomery Scott first reported a position in Oragenics in Q3 2013 and held it in 11 quarters.
  • Janney Montgomery Scott's Oragenics position peaked at $238K in Q2 2014.
  • 12 funds tracked by Wall St. Rank held Oragenics as of Q2 2016.

Based on Janney Montgomery Scott's 13F filing for Q2 2016, filed 5 Aug 2016.